Skip to main content
AKBA logo

AKBA · Akebia Therapeutics, Inc. · Short Interest

Track AKBA — free
$0.88 +0.01 (+1.03%)
Market Cap
$244.05M
Shares
277.11M
Volume · Oct 1 4.52M Avg daily vol (3M) 6.02M

Shares sold short and not yet covered, reported twice monthly. Days to cover is the reported short position divided by average daily volume.

AKBA Latest Reported Short Interest

FINRA reported 20,504,915 AKBA shares sold short as of the September 15, 2026 settlement date, a decrease of 2,497,646 shares. Days to cover was 2.76 based on FINRA's reported average daily volume.

Official FINRA short-interest data · share counts are restated for subsequent splits of this listing

AKBA Short Interest Forecast

Equibles' model estimates 22,599,633 shares sold short for the September 30, 2026 settlement, +10.2% versus the latest reported position, with a likely range of 19,380,309 to 26,816,540 shares. This model prediction uses FINRA data through September 30, 2026; FINRA's official release is expected October 9, 2026.

Model estimate

Expected Sep 30 short interest

as of Sep 30 High confidence 77% chance it rises
22,599,633 +10.2% vs reported
Likely range 19,380,309 to 26,816,540 The latest estimate appears in the chart below. Official release expected Oct 9. Methodology
Short Squeeze Score
53/100
Short interest 7.4% of shares — P82 Days to cover 2.8 — P42 Price vs VWAP -13.5% — P25 Short-volume trend +0.1% — P46 Short interest change -10.9% — P20 Worst FTD 0.05% of shares — P76

Positioning score 53.3 + catalyst boost 0 (total capped at 100). This is a screening index, not a probability of a squeeze.

Method and coverage limits

Factor percentiles compare eligible primary operating-company stocks reporting short interest at the latest settlement date (2026-09-15). The weighted mean uses short interest 30%, days to cover 20%, price vs VWAP 15%, short-volume trend 15%, short-interest change 10%, and fails-to-deliver 10%. Missing factors redistribute their weight; incomplete coverage is not evidence of low risk. Price, volume, and earnings boosts add 10 each, capped at 20.

Shares outstanding are not free float. Borrow fees, utilization, lendable supply, recalls, and dealer inventory are not measured. Short-sale volume does not measure the change in open shorts; fails to deliver are not a borrow-cost measurement; price vs VWAP does not establish short sellers' entry prices. Earnings can move prices in either direction.

The weights are judgment-based, not calibrated to future squeeze outcomes. The separate options assessment below does not change this universe ranking.

Options positioning & squeeze sensitivity

Nearest expiration after today within 30 calendar days; same-day expirations and later maturities are excluded.

Open interest is incomplete, stale, or dated inconsistently; positioning totals are unavailable.

Open interest has both a buyer and a seller; it does not reveal dealer hedge direction. Gross gamma sums both calls and puts without netting and uses a local 1% price-change approximation. It measures sensitivity, not predicted buying or a squeeze probability.

Assessment prepared 2026-10-02 09:33 UTC. Options model values may come from a cached snapshot; their original computation time is not supplied. Open interest has its own effective date.

Short Interest History

Settlement Date Current Position Previous Position Change Days to Cover
2026-10-15 Scheduled
FINRA publishes Oct 26
— — — —
2026-09-30 Scheduled
FINRA publishes Oct 9
— — — —
2026-09-15 20,504,915 23,002,561 -2,497,646 2.76
2026-08-31 23,002,561 21,371,566 +1,630,995 2.34
2026-08-14 21,371,566 19,183,020 +2,188,546 3.54
2026-07-31 19,183,020 19,076,806 +106,214 8.81
2026-07-15 19,076,806 19,177,371 -100,565 4.20
2026-06-30 19,177,371 29,201,925 -10,024,554 2.69
2026-06-15 29,201,925 27,420,606 +1,781,319 5.60
2026-05-29 27,420,606 26,371,163 +1,049,443 4.14
2026-05-15 26,371,163 27,621,774 -1,250,611 5.69
2026-04-30 27,621,774 27,313,287 +308,487 11.35
2026-04-15 27,313,287 26,266,098 +1,047,189 13.48
2026-03-31 26,266,098 28,988,090 -2,721,992 9.34
2026-03-13 28,988,090 29,692,868 -704,778 10.34
2026-02-27 29,692,868 31,207,330 -1,514,462 9.12
2026-02-13 31,207,330 36,927,875 -5,720,545 7.10
2026-01-30 36,927,875 37,025,281 -97,406 14.15
2026-01-15 37,025,281 36,058,633 +966,648 11.09
2025-12-31 36,058,633 34,581,801 +1,476,832 12.71
2025-12-15 34,581,801 35,918,701 -1,336,900 10.32
2025-11-28 35,918,701 35,344,201 +574,500 10.18
2025-11-14 35,344,201 35,517,452 -173,251 5.47
2025-10-31 35,517,452 29,319,644 +6,197,808 6.44
2025-10-15 29,319,644 29,401,452 -81,808 10.91

Full FINRA short interest reporting calendar

Showing 1–23 of 23 settlements
Key facts CIK 1517022 CUSIP 00972D105 13F (30d) 4 filings 4 filers Visit website Investor relations